Tetra Radar · FDA Approvals · Decision date

Gsk PLC: FDA decision date

Gsk PLC (GSK) · March 2026

Under the terms of the agreement, GSK will receive an upfront payment of $300 million, plus $100 million upon US FDA approval (expected prior to transaction closing, based on current PDUFA target approval date of 24 March 2026).

Source: 6-K of 9 March 2026

The date has passed; Tetra Radar has not recorded an approval.

Gsk PLC on Tetra Radar

A PDUFA date is the date by which the FDA has said it will decide on an application. Dates can move, and a decision is not an approval. Tetra Radar observes public information for research purposes. It does not provide investment advice.

Get the Dispatch free.